Dr. Chris Tackaberry
As the CEO of Clinithink, Chris Tackaberry’s drive to solve mounting healthcare challenges in the areas of “Big Data,” clinical workflow and research, point-of-care decision support and analytics lies within the ability to harness the power of unstructured data.
Read more +
In 2000 Chris brought his nine years of anesthesiology and intensive care experience, along with an MSc degree in Computer Science to iSoft, a UK-based EMR vendor operating in more than 35 countries. At iSOFT, Chris served in several key leadership roles including Head of Clinical R&D, Clinical Director (Chief Medical Officer) and Product Management Director, where he oversaw a portfolio of more than 30 products driving approximately $320M of total annual revenue. Leading a team of over 200 product managers, business analysts and designers, Chris was instrumental in establishing iSOFT as a major global player in healthcare IT.
Following his years with iSOFT, Chris built a successful consulting practice focused on technology strategy, product management and major systems implementation. His clients included Lion Television Inc., Silver Lake Partners, the UK Department of Health and Skype.
His vision to add meaning to, and get knowledge from, unstructured clinical data provides the direction for Clinithink and its technology.
We believe that our vision to provide a solution that accurately structures clinical narrative in a manner that supports physician workflow, enhances processes and ultimately, improves patient care will not only give the industry an opportunity to adequately access the information they are generating but also make a positive impact on healthcare delivery as a whole.
Peter Neupert serves as a consultant to private equity companies and as a board member of public and private companies in the health sector. He has recently done work with Health Evolution Partners where he focuses on the IT sector and with other leading PE firms.
Read more +
Previously, Peter served as Corporate Vice President of the Microsoft Health Solutions Group, and was responsible for driving the company’s strategy to improve healthcare around the world through software innovation. He lead a global organization dedicated to developing, marketing, selling and supporting software solutions designed to improve the quality and efficiency of healthcare delivery and to empower individuals to become more engaged and responsible for their own health and wellness.
Under his leadership, the Health Solutions Group brought two primary software platforms to market: Amalga, a data aggregation platform for hospitals and health systems, and HealthVault, a personal health application platform designed to put individuals in control of their own health information. Both software platforms are designed to unlock the health data traditionally stored in separate information technology systems and make it readily accessible to the people who need it— whether emergency room doctors, primary care physicians, nurses, specialists, patients, or family caregivers—to make more informed care decisions.
Although Peter began his career in technology, he became immersed in the world of health when he served as president and chief executive officer of drugstore.com Inc. from July 1998 to April 2001, and as chairman of the board of directors through September 2004. He led drugstore.com to become the leading online retail site for health, wellness, beauty and pharmacy products, and received an Ernst & Young Entrepreneur of the Year award for his work. From 2003 to 2005, he served on the President’s Information Technology Advisory Committee (PITAC), co-chairing the Health Information Technology subcommittee and helping to drive the “Revolutionizing Health Care through Information Technology” report, published in June 2004 by PITAC. Peter was an active member of the Institute of Medicine’s Roundtable on Value & Science-Driven Healthcare from 2009 through 2011.
Before drugstore.com, from 1987 to 1998, Peter served at Microsoft in various capacities, including as the director of operating systems responsible for shipping OS/2, and later for MSNBC as vice president of News and Publishing for the interactive media group.
Peter currently serves the board of directors of LabCorp Holdings of America, Freedom Innovations, LLC, Adaptive Biotechnologies Inc., higi llc, and Clinithink Ltd. and on the board of trustees for the Fred Hutchinson Cancer Research Center. Viewed as an industry authority, Peter has testified before Congress on multiple occasions, including in 2009 on health information technology reform. He speaks at industry conferences on innovation and the impact of technology, and has contributed to leading publications including Health Affairs, Forbes and The Washington Post. He shares his observations and opinions on health in his personal blog, Neupert on Health.
Peter holds a master’s degree in business administration from the Tuck School of Business at Dartmouth College and a bachelor’s degree from Colorado College. He is married with four children and lives in the state of Washington.
Having spent over 40 years in information systems and technology, Duncan McNeil has also served for over 30 years as a trusted consultant and advisor to senior management in various sectors, including healthcare.
Read more +
Originally independent, he founded Applied Systems Engineering (now ASE Consulting) in 1987 which he grew into a successful technology consulting firm. In addition to ASE, Duncan is responsible for establishing other start-ups in different sectors.
Duncan currently holds a number of board positions with innovative technology companies, in several of which he has also been an investor. In Clinithink, Duncan is both an angel and subsequent series A investor. He also serves on the board of non-profit organizations including the IHTSDO (The International Health Terminology Standards Development Organization), the association responsible for the management of SNOMED CT (Systematized Nomenclature of Medicine-Clinical Terms), the most comprehensive and precise clinical health terminology product in the world.
Duncan was previously nominated for the Sir Frank Whittle medal. This honor is awarded by the Royal Academy of Engineering in recognition of “outstanding and sustained achievement which has contributed to the well-being of the nation.”
Ernest E. “Lee” Keet is Vanguard Atlantic’s CEO and Chief Investment Officer. Mr. Keet co-founded Vanguard Atlantic Ltd. in 1984.
In 1985 Mr. Keet orchestrated the leveraged buyout of the information technology properties of Dun & Bradstreet and the subsequent reformation of part of these properties into TSI International Software, subsequently re-named Mercator Software. Mercator went public in 1996 and was shortly thereafter acquired by Ascential Systems, which was in turn acquired by IBM in 2005.
Read more +
In the late 1980s Mr. Keet helped build and subsequently sell Decision Technologies Inc. and Document Systems Inc. From its purchase by Vanguard Atlantic in 1988 until its sale in 1990, Lee was Chairman and CEO of Information Science Inc. a public (NASDQ) company.
Lee has also been responsible for the firms’ managed start-ups (Axolotl Corp., formed by Vanguard Atlantic in 1995 and sold to United Health Group in 2010, and ECsoft, formed in Europe by Vanguard Atlantic in 1990 and taken public (NASDQ) in 1996. From 1999 to the present he has led the firms’ investments in V2Commerce, Engenia, Extenex, ALARA, Technology Help, Inc., and Clinithink.
Mr. Keet holds a B.M.E. (a combined B.S. and M.S.) in Mechanical Engineering from Cornell University and a M.S. (in Operations Research) from New York University.
He is also the co-author (with Vanguard’s Jack Pendray) of Strategic Development for High-Technology Businesses, Value Publishing, 1988, and the author of Preventing Piracy, a Business Guide to Software Protection, Addison-Wesley, 1985. His two oral history interviews are posted to the Computer History Museum and Charles Babbage Institute websites. Two articles about his experiences in the early days of the software industry were published by the IEEE’s Annals of the History of Computing in December 2004 and in December 2005.
In addition to Vanguard Atlantic Ltd., Lee currently serves on the Boards of Directors of ALARA, Inc. and Packaged Business Solutions Inc. He had also served on the Boards of Axolotl Corp., Information Science Inc., Decision Technologies Inc., and Document Systems Inc.
His not-for-profit boards include the Adirondack Council where he is Government Affairs Chair, the Adirondack Nature Conservancy, AdkAction.org (where he was co-founder, past President, and is currently Water Quality Chair), Adirondack Recreational Trail Advocates (ARTA), the Lake Colby Association, and the Keet Foundation. He had also served on the Boards of the Software Industry Association, ADAPSO (now ITAA), the Trudeau Institute, the IT History Society and the Computer and Communications Industry Association (CCIA).
Barbara E. Bierer, M.D.
Barbara E. Bierer, M.D., a hematologist-oncologist, is a Professor of Medicine at Harvard Medical School and the Brigham and Women’s Hospital.
Read more +
Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center at Harvard and the Brigham and Women’s Hospital (MRCT Center, www.mrctcenter.org), a University-wide and collaborative effort to improve standards for the planning and conduct of international clinical trials with a particular focus in the developing world. In this capacity, she works with regulators around the world (USFDA, EMA, CFDA, CDSCO, KFDA, MCC and others), major pharmaceutical companies, the biotech industry, clinical research organizations and academia to harmonize policies for and approaches to clinical trial regulation.
In addition, she is the Director of the Regulatory Foundations, Ethics, and the Law program at the Harvard Catalyst, the Harvard Clinical and Translational Science Award, working across the academic spectrum to enable clinical trial recruitment efficiently and cooperatively. From 2003 – 2014, Dr. Bierer served as Senior Vice-President, Research at the Brigham and Women’s Hospital (BWH) where she grew the annual budget from $200 million to $660 million and reduced the research deficit of $95 million to zero.
During her tenure in this role, Dr. Bierer founded and served as Executive Sponsor of the Brigham Research Institute and the Brigham Innovation Hub (iHub), a focus for entrepreneurship and innovation in healthcare. She created and chaired Strategic Innovation in research at the BWH. She established the Center for Faculty Development and Diversity.
Earlier in her career, Dr. Bierer served as Vice-President of Patient Safety and Director of the Center for Patient Safety at the Dana Farber Cancer Institute (2002-3) and Chief of Laboratory of Lymphocyte Biology at the National Heart, Lung and Blood Institute of the National Institutes of Health in Bethesda, MD (1997-2002). She has held positions as director of pediatric stem cell transplantation at Dana-Farber Cancer Institute and Children’s Hospital.
Previously, Dr. Bierer served on the Board of Directors of ViaCell, a publicly-traded biotech company (NASDAQ: VIAC) that was acquired by Perkin Elmer in 2007. For the past eight years, she has served on the Advisory Board and now as a Venture Partner of Tullis Health Investors, a private equity firm considered a pioneer in health care-focused venture and growth capital. Tullis invests in all major areas of the healthcare industry, providing equity and equity-related capital to small and emerging healthcare companies as well as those with established operations who are looking to expand and continue their development.
Dr. Bierer Chairs the Board of the Edward P. Evans Foundation, a foundation supporting biomedical research and serves on the Boards of Directors of Public Responsibility in Medicine and Research (PRIM&R) and Management Sciences for Health (MSH). She chaired the Secretary’s Advisory Committee for Human Research Protections. She has authored or co-authored over 180 publications.
Dr. Bierer graduated from Harvard Medical School, completed her internal medicine residency at the Massachusetts General Hospital and her hematology and medical oncology training at the Brigham and Women’s Hospital and the Dana-Farber Cancer Institute. She lives outside of Boston, MA with her husband, Steven Hyman, MD, and their three grown children.